Table 2.
Relationship between VAI and hypertension in different models.
| Character | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
| Per 1 unit increase % | 1.29 (1.24,1.33) | <0.0001 | 1.26 (1.21,1.30) | <0.0001 | 1.17 (1.12, 1.22) | <0.0001 |
| VAI group | ||||||
| Q1 (0 < VAI ≤ 0.870) | 1(ref) | 1(ref) | 1(ref) | |||
| Q2 (0.870 < VAI ≤ 1.420) | 1.55 (1.34,1.78) | <0.0001 | 1.48 (1.27,1.73) | <0.0001 | 1.39 (1.15, 1.68) | <0.001 |
| Q3 (1.420 < VAI ≤ 2.371) | 2.08 (1.80,2.39) | <0.0001 | 1.90 (1.64,2.20) | <0.0001 | 1.60 (1.33, 1.92) | <0.0001 |
| Q4 (2.371 < VAI) | 2.89 (2.50,3.34) | <0.0001 | 2.57 (2.21,2.99) | <0.0001 | 1.95 (1.62, 2.35) | <0.0001 |
| p for trend | <0.0001 | <0.0001 | <0.0001 | |||
Model 1: non-adjusted.
Model 2: adjutesd age, gender and race.
Model 3: adjutesd age, gender, race, education, marital, PIR, smoke, alcohol, eGFR, DM, CHD, antiHyperlipidemic and antiHypertensive.
PIR, poverty-to-income ratio; eGFR, estimated glomerular filtration rate; DM, diabetes mellitus; CHD, coronary heart disease.